ISPOR ANNOUNCES CALL FOR NOMINATIONS

Published Oct 19, 2015
SUBMISSIONS BEING ACCEPTED FOR 2016-2017 BOARD OF DIRECTORS Princeton, NJ—October 19, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it is accepting nominations for the 2016-2017 Board of Directors. Board openings include President-Elect and four Director positions. As a member-driven organization, ISPOR relies on the participation of its members to fulfill the organization’s mission. Participating on the Board enables ISPOR members to lend their leadership, expertise, and vision to the discipline of health economics and outcomes research. The Board of Directors drives ISPOR’s strategic direction and is responsible for the management of the Society, including its committees, publications, budget and governance. The Board is the policy making body of the Society. Members may submit nominations on behalf of other ISPOR members or may self-nominate. Additional details on the nomination process may be found at http://www.ispor.org/board/CallForNominations-BOD2016.asp. Information on the 2015-2016 Board of Directors members (including terms of office) can be found at http://www.ispor.org/board/index.asp. The deadline for submitting nominations is January 1, 2016.

###

Related Stories

ISPOR Announces New Strategic Plan 2030

Jul 29, 2024

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×